Retired for over 10 years, Isadore hasn’t slowed down. After being diagnosed with advanced prostate cancer at the age of 56, Isadore immediately started treatments and remained progression-free for almost 10 years. In 2007, when a friend was also diagnosed with prostate cancer, they started a local prostate cancer survivor’s support group called The Empowerment Network. In 2011, Isadore’s cancer progressed and his physician recommended PROVENGE (sipuleucel-T). Isadore liked the idea of using the body’s own immune system to fight cancer. He was infused in 2011 and continues to run The Empowerment Network, which now has over 200 members. His children and grandchildren keep him grounded, and his passion to help educate and support other men with this disease keeps him motivated for the future.

 
 

Hiking, biking, snow skiing, water skiing, kayaking and playing music are just a few of the activities that Todd and his family enjoy on a regular basis. So, at only 42 years old, Todd never expected he'd be diagnosed with advanced prostate cancer. With four children, five grandchildren, and a new wife, he had too much to live for to give up. Todd worked vigilantly with his physicians to come up with a treatment plan that included PROVENGE (sipuleucel-T). After initial treatments stopped working and his cancer progressed, Todd received PROVENGE in mid-2012. Never taking life for granted, Todd truly enjoys the adventures he shares with his family and his hope for the future remains strong.

 
 

As a fifth-grade teacher with three children and two grandchildren, Tim is always on the move, whether he's teaching, surfing, cycling, or enjoying the outdoors with his family. Tim never thought he'd be battling prostate cancer at 52 years old. After the initial shock of diagnosis, he decided he couldn't let prostate cancer slow him down. When his cancer spread after two years of treatment, his doctor recommended PROVENGE (sipuleucel-T), which he received in early in 2012. Tim's fifth-grade students still keep his life busy, but his family helps him live it to the fullest.

 
 

Diagnosed with prostate cancer more than 15 years ago at the age of 62, Don was told he wouldn't likely live more than 5 or 10 years. After enduring multiple treatments including surgery, radiation, and hormone treatments, Don was put on PROVENGE (sipuleucel-T) in 2011 and never looked back. Don used to say he always wanted to be 80 years old. Now, with that age just around the corner, he's excited about the possibility of reaching 90! With his renewed zest for life, Don and his wife Kris are planning to travel more, but while they are home on their 30 acre farm, they enjoy the comfort of their animals and managing their booming fine art and document restoration business.

 
 

Rollin hasn't let his 19-year battle with prostate cancer hold him back from doing what he loves most: packing up his RV and traveling all over the country to visit friends and family. When Rollin's physician told him about a clinical trial of PROVENGE (sipuleucel-T), Rollin was eager to explore this innovative treatment option. Rollin's physicians and faith keep him optimistic about the future, and he enjoys living life to the fullest. Aside from his wife and three sons, Rollin spends quality time with the “Sun Ray Eight” – his close-knit group of Floridian friends.

 
 
Provenge.com

PROVENGE® (sipuleucel-T) is the first and only FDA-approved immunotherapy for advanced prostate cancer. PROVENGE takes the body’s own immune cells and reprograms them to attack advanced prostate cancer.

LEARN
MORE >>

 
OUR PRODUCT PLATFORM

PROVENGE is different from other kinds of prostate cancer medicine. To see how PROVENGE is manufactured and designed to work, watch a video that explains the PROVENGE process.

HOW PROVENGE IS MADE>>

COMPANY INFORMATION

Dendreon has reached agreements with certain of its senior noteholders on the terms of a financial restructuring. Operations will continue in the ordinary course and PROVENGE will remain available. Additional information about the financial restructuring is available here: https://cases.primeclerk.com/
dendreon
.

INDICATION: PROVENGE® (sipuleucel-T) is approved by the FDA as an autologous cellular immunotherapy for the treatment of asymptomatic or minimally symptomatic metastatic castrate resistant (hormone refractory) prostate cancer.
Important Safety Information | Full Prescribing Information